These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11449664)

  • 1. Role of long-acting cephalosporins in the treatment of lower respiratory tract infections.
    Lode H; Eller J; Raffenberg M; Mauch H
    Clin Microbiol Infect; 2000; 6 Suppl 3():87-9. PubMed ID: 11449664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cefotaxime (klaforan) in modern therapy of bacterial infections].
    Khess R; Budanov SV
    Antibiot Khimioter; 1996 Mar; 41(3):44-56. PubMed ID: 8967803
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
    Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
    Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
    Lanni N; Scaglione B
    Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of ceftizoxime and cefamandole in the treatment of serious lower respiratory tract infections.
    Rodriguez J; Vazquez GJ; Bermudez RH; Luina A; Ronda CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():209-13. PubMed ID: 6296008
    [No Abstract]   [Full Text] [Related]  

  • 7. Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.
    Shah PM; Stille W
    Diagn Microbiol Infect Dis; 1995; 22(1-2):171-2. PubMed ID: 7587035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of parenteral cephalosporins in community-acquired lower respiratory tract infections.
    Concia E
    Clin Microbiol Infect; 2000; 6 Suppl 3():84-6. PubMed ID: 11449663
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cephalosporins of the third generation in therapy of children with severe infections].
    Samsygina GA
    Antibiot Khimioter; 2000; 45(12):32-3. PubMed ID: 11212493
    [No Abstract]   [Full Text] [Related]  

  • 10. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP; Gelfand MS; Grogan J; Craft B
    Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections.
    Boccazzi A; Tonelli P; Bellosta C; Careddu P
    Diagn Microbiol Infect Dis; 1998 Dec; 32(4):265-72. PubMed ID: 9934543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A well-controlled comparative study on ceftriaxone with cefotaxime in respiratory tract infections].
    Kobayashi H; Takamura K; Oshitani H; Nihei T; Saito A; Tomizawa M; Nakayama I; Ishikawa K; Abe M; Kuroda Y
    Kansenshogaku Zasshi; 1986 Feb; 60(2):102-24. PubMed ID: 3090162
    [No Abstract]   [Full Text] [Related]  

  • 13. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefotaxime in healthy volunteers and patients.
    Patel KB; Nicolau DP; Nightingale CH; Quintiliani R
    Diagn Microbiol Infect Dis; 1995; 22(1-2):49-55. PubMed ID: 7587050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
    Barradas P; Zamith M; Videira W; Cardosa T; Marques RA; Avila R
    Chemotherapy; 1989; 35 Suppl 2():33-40. PubMed ID: 2612238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone once daily compared with four daily doses of cefotaxime in the treatment of severe gram-negative septicemia or pyemia: a randomized study.
    Leu HS; Lasserre R
    Changgeng Yi Xue Za Zhi; 1995 Mar; 18(1):36-42. PubMed ID: 7767852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E
    Respiration; 1986; 49(3):222-30. PubMed ID: 3515468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefotaxime in dialysis patients.
    Andrassy K
    Diagn Microbiol Infect Dis; 1995; 22(1-2):85-7. PubMed ID: 7587055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential use of cephalosporins in treatment of upper and lower respiratory tract infections].
    Dvoretskiĭ LI; Omel'ianovskiĭ VV
    Antibiot Khimioter; 1998; 43(6):24-8. PubMed ID: 9644531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM
    Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.